主页文献库搜索
VEGF-D expression and EGFR mutations in non-small-cell lung carcinoma.

Wang(Z),Wu(Y),Guo(A),Chen(Z),Su(J),Huang(Y... J Clin Oncol 0000-00-00

...KRAS gene mutation ratio was 12.7% (7/55). Inverse relationship between KRAS and EGFR mutations in the non-small-cell lu...

Comparison of CISH and FISH for detection of EGFR copy number in lung adenoca...

Varella-Garcia(M),Ladanyi(M),Kris(M G),Li(... J Clin Oncol 0000-00-00

...KRAS mutation. No other KRAS mutant case was scored as EGFR-amplified by either method. EGFR was positive by IHC in 28 c...

Insuline like growth factor receptor-1 (IGFR-1), MET, and BRAF and primary re...

Finocchiaro(G),Cappuzzo(F),Rossi(E),Toschi... J Clin Oncol 0000-00-00

...KRAS mutations cannot account for all resistant cases. Preclinical data suggested that MET could interfere with anti-EGF...

Additional value of EGFR downstream signaling phosphoprotein expression to KR...

Merlin(J L),Perkins(G),Lièvre(A),Ramacci(C... J Clin Oncol 0000-00-00

...KRAS mutated tumors than in non mutated tumors (p<.04). In Cox multivariate analysis adjusted for age and gender KRAS an...

Correlation of KRAS status (wild type [wt] vs. mutant [mt]) with efficacy to ...

Cervantes(A),Macarulla(T),Martinelli(E),Ro... J Clin Oncol 0000-00-00

...KRAS status of these pts.,KRAS mutations were detected in 19 samples (40%) from the KRAS evaluable population. At the en...

Panitumumab (pmab) regimen evaluation in colorectal cancer to estimate primar...

Cohn(A L),Smith(D A),Neubauer(M A),Houston... J Clin Oncol 0000-00-00

...KRAS gene in tumors has been shown to be a predictive biomarker of response to anti-EGFr antibody monotherapy in mCRC. T...

Mutational profiling of the oncogenome in non-small cell lung cancer (NSCLC).

Pao(W),McLellan(M D),Pham(D K),Singh(B),Ru... J Clin Oncol 0000-00-00

...KRAS mutations are found in tumors refractory to these agents (Pao et al, PLoS Med '05). Moreover, EGFR and KRAS mutatio...

EGFR and KRAS mutations in patients with bronchioloalveolar carcinoma treated...

Kris(M G),Sandler(A),Miller(V A),Zakowski(... J Clin Oncol 0000-00-00

...KRAS in 4 of 34 (12%). In the 11 patients with partial responses, mutations in EGFR were found in 9 (82%) and in KRAS in...

Exploratory analyses EGFR, kRAS mutations and other molecular markers in tumo...

Gatzemeier(U),Heller(A),Foernzler(D),Moeck... J Clin Oncol 0000-00-00

...kRAS mutation analysis was performed on a set of 293 formalin-fixed tissue samples. Tumor cells were microdissected to e...

Phase II study of gefitinib treatment in advanced thymic malignancies.

Kurup(A),Burns(M),Dropcho(S),Pao(W),Loehre... J Clin Oncol 0000-00-00

...KRAS2 exon 2).,All 26 pts were evaluated for response and toxicity. There were 0 CRs, 1 PR (response duration = 5 months...

上一页 947 948 949 950 951 952 953 下一页 951 / 共 953

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: [email protected]